No-Needle chemo patch takes aim at skin cancer
Disease control
Completed
This study tested a microneedle patch that delivers the chemotherapy drug doxorubicin directly into nodular basal cell carcinoma, a common skin cancer. 90 adults with small, untreated tumors received either a low-dose, high-dose, or no-drug patch. The goal was to see if the patch…
Phase: PHASE2 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC